Lecture: The GLP1 landscape - refining our understanding

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Two choices of drugs that reduce CV risk in T2DM
Two choices of drugs that reduce CV risk in T2DM
CDMC 2018: Shifting gears in the management of diabetes and CVD
Two choices of drugs that reduce CV risk in T2DM
- Prof. John Deanfield, MD
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
- Prof. Richard Hobbs, MD
Lecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?
Lecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?
- Prof John E Deanfield
Lecture: The clinical landscape for T2DM and CVD: impact on guidelines and practice
Lecture: The clinical landscape for T2DM and CVD: impact on guidelines and practice
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: The clinical landscape for T2DM and CVD: impact on guidelines and practice
- Prof John E Deanfield